RNXT Stock News

Popular stocks:

NVIDIA

TOP Stocks:

Shares of other companies:

Post Holdings Partnering

ReneSola

Paysafe

Jumia Technologies

RenovoRx (RNXT) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 5, 2023 (10:51)

Sector: Healthcare

The share price of RenovoRx, Inc. (RNXT) now

Latest session on the 5th of December for

RenovoRx, Inc. is negative

Trading Volume: 38604

Open: 0.65 / High: 0.675 / Low: 0.601

What analysts predict: $7

52-week High/Low: $5.75 / $0.55

50/200 Day Moving Average: $1.018 / $2.132

This figure corresponds to the Average Price over the previous 50/200 days. For RenovoRx stocks, the 50-day moving average is the resistance level today.

For RenovoRx stocks, the 200-day moving average is the resistance level today.

Are you interested in RenovoRx, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the RenovoRx stock price in 2024, 2025, 2026, 2027, 2028. How much will one RenovoRx share be worth in 2024 - 2028?

When should I take profit in RenovoRx stock? When should I record a loss on RenovoRx stock? What are analysts' forecasts for RenovoRx stock? What is the future of RenovoRx stock? We forecast RenovoRx stock performance using neural networks based on historical data on RenovoRx stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

RenovoRx stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for RenovoRx shares. This happens once a day.

Historical and forecast chart of RenovoRx stock

The chart below shows the historical price of RenovoRx stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the RenovoRx stock price can be found in the table below.

Long-term forecasts by years.

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for the local treatment of solid tumors. Its therapy platform, RenovoRx, handles the optimizing drug concentration in solid tumors using approved small molecule chemotherapeutics that enable physicians to isolate segments of the vascular anatomy closest to tumors and force chemotherapy across the blood vessel wall to bathe these difficult-to-reach tumors in chemotherapy. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Los Altos, CA.

RenovoRx daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Dec 07	0.65	0.61	0.69	11.97
Dec 08	0.65	0.61	0.67	9.82
Dec 09	0.69	0.65	0.72	10.82
Dec 10	0.72	0.65	0.74	14.20
Dec 11	0.80	0.75	0.88	17.54
Dec 12	0.86	0.78	0.90	15.54
Dec 13	0.82	0.77	0.86	11.76
Dec 14	0.83	0.80	0.90	12.46
Dec 15	0.78	0.75	0.81	7.75
Dec 16	0.77	0.73	0.81	10.15
Dec 17	0.77	0.74	0.82	10.59
Dec 18	0.73	0.67	0.79	16.75
Dec 19	0.70	0.67	0.75	10.84
Dec 20	0.74	0.69	0.80	15.50
Dec 21	0.72	0.68	0.78	15.83
Dec 22	0.80	0.78	0.87	11.56
Dec 23	0.80	0.73	0.82	13.41
Dec 24	0.88	0.80	0.94	17.54
Dec 25	0.89	0.85	0.94	10.98
Dec 26	0.82	0.77	0.88	13.10
Dec 27	0.77	0.72	0.81	12.43
Dec 28	0.81	0.79	0.89	12.71
Dec 29	0.83	0.80	0.88	9.65
Dec 30	0.85	0.77	0.91	18.05
Dec 31	0.93	0.89	0.99	10.93
Jan 01	0.91	0.88	1.00	13.83
Jan 02	0.90	0.84	0.97	16.08
Jan 03	0.81	0.74	0.88	19.60
Jan 04	0.78	0.72	0.83	14.83
Jan 05	0.72	0.70	0.77	9.66

RenovoRx Daily Price Targets

RenovoRx Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $0.65.
Negative dynamics for RenovoRx shares will prevail with possible volatility of 10.690%.
Pessimistic target level: 0.61
Optimistic target level: 0.69

RenovoRx Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $0.65.
Positive dynamics for RenovoRx shares will prevail with possible volatility of 8.940%.
Pessimistic target level: 0.61
Optimistic target level: 0.67

RenovoRx Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $0.69.
Positive dynamics for RenovoRx shares will prevail with possible volatility of 9.766%.
Pessimistic target level: 0.65
Optimistic target level: 0.72

RenovoRx Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $0.72.
Positive dynamics for RenovoRx shares will prevail with possible volatility of 12.437%.
Pessimistic target level: 0.65
Optimistic target level: 0.74

RenovoRx Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $0.80.
Positive dynamics for RenovoRx shares will prevail with possible volatility of 14.923%.
Pessimistic target level: 0.75
Optimistic target level: 0.88

RenovoRx Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $0.86.
Positive dynamics for RenovoRx shares will prevail with possible volatility of 13.450%.
Pessimistic target level: 0.78
Optimistic target level: 0.90

RNXT (RNXT) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan.	0.73	0.64	0.77	16.95
Feb.	0.79	0.67	0.89	24.96
Mar.	0.77	0.69	0.85	18.15
Apr.	0.64	0.57	0.72	21.42
May.	0.65	0.55	0.70	21.67
Jun.	0.68	0.65	0.71	9.02
Jul.	0.69	0.59	0.79	25.74
Aug.	0.70	0.63	0.80	22.11
Sep.	0.76	0.66	0.79	16.31
Oct.	0.70	0.62	0.73	14.99
Nov.	0.72	0.61	0.79	23.69
Dec.	0.69	0.63	0.75	15.62

Full forecast for 2024

RenovoRx forecast for this year

RenovoRx Stock Prediction for Jan 2024

An uptrend is forecast for this month with an optimal target price of $0.7267. Pessimistic: $0.64. Optimistic: $0.77

RenovoRx Stock Prediction for Feb 2024

An uptrend is forecast for this month with an optimal target price of $0.79065. Pessimistic: $0.67. Optimistic: $0.89

RenovoRx Stock Prediction for Mar 2024

An downtrend is forecast for this month with an optimal target price of $0.76693. Pessimistic: $0.69. Optimistic: $0.85

RenovoRx Stock Prediction for Apr 2024

An downtrend is forecast for this month with an optimal target price of $0.638086. Pessimistic: $0.57. Optimistic: $0.72

RenovoRx Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $0.647019. Pessimistic: $0.55. Optimistic: $0.70

RenovoRx Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $0.680664. Pessimistic: $0.65. Optimistic: $0.71

RenovoRx Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $0.692916. Pessimistic: $0.59. Optimistic: $0.79

RenovoRx Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $0.704003. Pessimistic: $0.63. Optimistic: $0.80

RenovoRx Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $0.756099. Pessimistic: $0.66. Optimistic: $0.79

RenovoRx Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $0.695611. Pessimistic: $0.62. Optimistic: $0.73

RenovoRx Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $0.71787. Pessimistic: $0.61. Optimistic: $0.79

RenovoRx Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $0.68772. Pessimistic: $0.63. Optimistic: $0.75

RenovoRx (RNXT) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	0.69	0.66	0.78	15.75
Feb	0.66	0.63	0.74	14.34
Mar	0.70	0.60	0.76	21.00
Apr	0.74	0.68	0.79	13.75
May	0.86	0.78	0.98	19.93
Jun	0.79	0.74	0.83	10.63
Jul	0.75	0.69	0.86	19.47
Aug	0.80	0.68	0.89	23.75
Sep	0.71	0.60	0.77	22.22
Oct	0.74	0.67	0.82	18.56
Nov	0.67	0.59	0.70	15.96
Dec	0.79	0.72	0.82	13.08

Full forecast for 2025

RenovoRx (RNXT) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	0.72	0.66	0.81	17.73
Feb	0.66	0.59	0.69	15.34
Mar	0.67	0.61	0.75	18.65
Apr	0.61	0.53	0.69	24.26
May	0.50	0.42	0.53	20.38
Jun	0.41	0.38	0.47	18.89
Jul	0.42	0.40	0.49	17.01
Aug	0.43	0.38	0.46	17.41
Sep	0.41	0.39	0.45	13.20
Oct	0.44	0.40	0.49	18.77
Nov	0.53	0.44	0.57	21.79
Dec	0.63	0.57	0.73	21.80

Full forecast for 2026

RenovoRx (RNXT) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	0.71	0.63	0.78	19.12
Feb	0.72	0.64	0.75	15.27
Mar	0.70	0.65	0.77	14.96
Apr	0.64	0.56	0.70	19.71
May	0.58	0.53	0.64	16.91
Jun	0.63	0.59	0.68	13.06
Jul	0.62	0.57	0.66	13.70
Aug	0.63	0.58	0.69	15.60
Sep	0.76	0.65	0.83	22.04
Oct	0.73	0.68	0.77	11.51
Nov	0.82	0.79	0.86	8.62
Dec	0.90	0.80	0.96	16.64

Full forecast for 2027

RenovoRx (RNXT) Monthly Stock Prediction for 2028

Month	Target	Pes.	Opt.	Vol., %
Jan	0.85	0.75	0.95	20.36
Feb	0.87	0.81	0.92	11.74
Mar	0.84	0.78	0.88	11.52
Apr	0.71	0.62	0.82	24.83
May	0.74	0.65	0.85	23.99
Jun	0.68	0.60	0.74	19.37
Jul	0.64	0.56	0.70	19.49
Aug	0.63	0.59	0.68	13.70
Sep	0.73	0.68	0.81	16.03
Oct	0.76	0.65	0.82	20.00
Nov	0.79	0.71	0.87	19.02
Dec	0.90	0.80	0.99	19.38

Full forecast for 2028

RenovoRx information and performance

RenovoRx Address

333 W. SANTA CLARA STREET, SUITE 900, SAN JOSE, CA, US

Market Capitalization: 6 950 800 $

Market capitalization of the RenovoRx, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of RNXT shares in the company outstanding by the market price of one share.

EBITDA: -11 784 500 $

EBITDA of RenovoRx is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.92

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -0.334

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 10693600

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

AN2 Therapeutics, Inc. (ANTX)

BeyondSpring Inc. (BYSI)

Mirati Therapeutics, Inc. (MRTX)

BiondVax Pharmaceuticals Ltd. (BVXV)

PepGen Inc. (PEPG)

Edwards Lifesciences Corp. (EW)

Boston Scientific Corp. (BSX)

Nuvectis Pharma, Inc. (NVCT)

Vaccinex, Inc. (VCNX)

MediciNova, Inc. (MNOV)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/RNXT.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/RNXT.svg"> RenovoRx (RNXT) Stock Forecast for 2023 – 2026. Sell or Buy?